Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time.

Sandmann, Frank G

Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time. [electronic resource] - Health policy (Amsterdam, Netherlands) Oct 2013 - 285-96 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1872-6054

10.1016/j.healthpol.2013.03.006 doi


Adalimumab
Anti-Inflammatory Agents--economics
Antibodies, Monoclonal, Humanized--economics
Antineoplastic Agents--economics
Benzamides--economics
Decision Making
Drug Costs--statistics & numerical data
Economics, Pharmaceutical
Evidence-Based Practice
Filgrastim
Granulocyte Colony-Stimulating Factor--economics
Health Expenditures--statistics & numerical data
Humans
Imatinib Mesylate
Insurance, Health, Reimbursement--economics
Netherlands
Piperazines--economics
Polyethylene Glycols
Pyrimidines--economics
Recombinant Proteins--economics
Reimbursement Mechanisms
Uncertainty